Top Markets
Coin of the day
SQI Diagnostics Inc. SQI Diagnostics Inc.

SQI Diagnostics Inc.

SQIDF
Rank in Stocks #34184
SQI Diagnostics Inc. operates as a precision medicine firm, engaged in the... SQI Diagnostics Inc. operates as a precision medicine firm, engaged in the global identification, advancement, and marketing of swift diagnostic solutions tailored for medical professionals, patients, and the general public. Its diverse product portfolio features TOR-dx, a specialized lung test designed to help surgeons evaluate the condition of donor lungs. The company also offers an at-home antibody test kit for COVID-19, along with RALI-Dx, a laboratory-based test for triaging COVID-19 severity, and RALI-fast, its rapid point-of-care alternative for the same purpose. Furthermore, SQI Diagnostics provides essential microarray instruments to support antibody testing procedures. The company was founded in 1999 and maintains its corporate headquarters in Toronto, Canada.
Share Price
$0.0149
Last synced: 2023-06-14
Market Cap
$6.07M
Change (1 day)
14.62%
Change (1 year)
0.00%
Country
CA
Trade SQI Diagnostics Inc. (SQIDF)

Category

P/E ratio for SQI Diagnostics Inc. (SQIDF)
P/E ratio as of 2026 TTM: 0
According to SQI Diagnostics Inc. latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 0. At the end of 2026 the company had a P/E ratio of 0.
P/E ratio history for SQI Diagnostics Inc. from 2026 to 2026
P/E ratio at the end of each year
Year P/E Ratio Change
Not enough data for the provided dates.
P/E ratio for similar companies or competitors
Company P/E Ratio P/E Ratio Difference Country
31.59 -
US
35.83 -
US
- -
CN
-227.89 -
US
38.69 -
US
How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share.
A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.

Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.